Similar Articles
991 Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma
992 Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation
993 Current status and perspectives of immune-based therapies for hepatocellular carcinoma
994 Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
995 Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
996 Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
997 Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes
998 Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma
999 Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review
1000 Comparison of percutaneous radiofrequency ablation and CyberKnife® for initial solitary hepatocellular carcinoma: A pilot study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA